NVTC

Health Care Informatics & Analytics Conference

May 5, 2016

Emcee
Gerald L. Gordon, Ph.D.
President and CEO
Fairfax County Economic Development Authority


Gerald L. Gordon, Ph.D., is the president and CEO of the Economic Development Authority in Fairfax County, Virginia, the second-largest suburban office market in the nation and the largest in the Commonwealth of Virginia. He has been with the FCEDA since late 1983, during which time office space in the county grew from 32 million square feet to more than 116 million, and jobs in the county grew from 243,000 to almost 600,000. In 2010, Virginia Business named Gordon its "Virginia Business Person of the Year." That year he also received the James Rees Award from the Fairfax County Chamber of Commerce. In 2013, 2014, 2015 and 2016, Virginia Business tapped Gordon for its "50 Most Influential Virginians" list. In 2015, the International Economic Development Council (IEDC) awarded Gordon its Jeffrey A. Finkle Organizational Leadership Award that is presented to individuals who have led economic development organizations for at least 15 years.

He is the author of 12 books on strategic planning and economic development. His most recent book is "The Economic Survival of America's Isolated Small Towns" (CRC Press, 2015). Other books include "The Economic Viability of Micropolitan America" (CRC Press, 2013), "Reinventing Local and Regional Economies" (CRC Press, 2011) and "The Formula for Economic Growth on Main Street America" (CRC Press, 2009).



Keynote Speakers:



Christopher Barrett, Ph.D.
Director
Biocomplexity Institute of Virginia Tech National Capital Region


Chris Barrett received a Ph.D. in bioinformation systems in 1985 and an MS in engineering science in 1983 from the California Institute of Technology. Prior to joining the Biocomplexity Institute of Virginia Tech, he lead a research group at the Naval Air Development Center focused on the integration of machine and human intelligence in naval aircraft and later was leader of the Basic and Applied Simulation Science Group at the Los Alamos National Laboratory (LANL). At LANL Barrett built up a research group active in theoretical and applied research in complex systems, particularly those related to biological and social computation, interdependent societal infrastructures, computational epidemiology and synthetic information systems. The computational work is grounded in a basic research program in mathematics, theoretical computer science and the basic science of HPC-enabled representation of very large systems in great detail. After retiring from LANL he established the Network Dynamics and Simulation Laboratory at Biocomplexity Institute. At Biocomplexity Institute he has extended the scope of informatics research in biosocial complex systems.

Barrett has scientific experience in simulation, synthetic information systems, computational social and psychological science, scientific computation, algorithm theory and development, network science, system science and control, artificial intelligence, biosystems analysis, decision science, cognitive science. His research is largely devoted to the development and use of large-scale, high performance synthetic information systems. Barrett has received Distinguished Service Awards from the U.S. Navy, Los Alamos National Laboratory, the Alliance for Transportation Research and the Royal Institute of Technology in Stockholm, and was named a Jubileum Professor of Computer Science at Göteborg University in Sweden.

In 2014, Barrett was named Executive Director of the Biocomplexity Institute at Virginia Tech.



David A. Dworaczyk, Ph.D.
Director of Life and Health Sciences Strategic Development
Oracle


Dr. David A. Dworaczyk has done extensive work with numerous healthcare, pharma, biotech, diagnostic and CRO-focused venture and private equity investment groups assessing and evaluating investment opportunities from an operational, strategic and business potential perspective. He is currently the director of life and health sciences strategic development at Oracle and has also served as COO for Comprehensive Clinical Development; senior vice president, general manager and COO at Generation Health/MetaDiagnostic, a startup focused on molecular diagnostics, genomics and personalized medicine; and was COO for M2Gen, a for-profit subsidiary of the Moffitt Cancer Center. His responsibilities included leading all operational functions across multiple business units with extensive experience in genomics/biomarkers, translational medicine, patient targeted drug development, personalized medicine as well as the integration and effective use of "Big/Complex" data and healthcare analytics.

Dworaczyk has more than 30-yrs of experience in the pharmaceutical, biotechnology, molecular diagnostic, medical device and CRO industry where he has held senior level positions in R&D, global operations, business development (L&A/M&A), clinical development, strategic planning, project management, commercial operations and healthcare analytics. He has been directly engaged in startup companies and turn-around situations. He has also gained expertise in decision and risk analysis, and has done extensive research in strategic planning, R&D portfolio management. Dworaczyk has advanced degrees in cell and molecular biology and in leadership and business administration.



Dr. Shahram Ebadollahi
Vice President, Innovations & Chief Science Officer
IBM Watson Health Group


Dr. Shahram Ebadollahi is the vice president of innovations and the chief science officer of IBM Watson Health Group. As the head of innovations, he oversees development, solutions, and strategic partnerships for IBM Watson Health business unit. In his capacity as the chief scientific officer, he has global responsibility for the innovation and technical strategy for IBM Watson Health and the global health informatics research in IBM Research.

Prior to joining IBM Watson Health in April 2015, Ebadollahi was the global leader of Health Informatics Research in IBM. He and his team of scientists across IBM Research have conducted research in the broad area of health informatics, with specific focus on computational healthcare, and also have enabled software and services in the area of data-driven analytics and big data for healthcare and life sciences applications. His pioneering work in computational healthcare has become one of the key underpinnings of the strategy and direction of IBM Watson Health.

Ebadollahi joined IBM as a research scientist in 2005. Prior to that, he received his Ph.D. and MS degrees in electrical engineering from Columbia University with specialization in multi-modal content analysis and retrieval and their applications to the domain of medicine. He has served as adjunct faculty at Columbia University, and also has served on thesis committees of several doctoral students in the areas of medical imaging or multimedia analysis. He has numerous publications and patents in the areas of multimedia content analysis, medical imaging, and healthcare analytics, and is a frequent speaker at various scientific events.



Todd Stottlemyer
CEO
Inova Center for Personalized Health


Todd Stottlemyer joined Inova in July 2015 as chief executive officer of Inova Center for Personalized Health (ICPH). Stottlemyer is responsible for developing and growing all activities on the 117-acre ICPH campus, which includes Inova Schar Cancer Institute and Inova Translational Medicine Institute (ITMI).

Stottlemyer previously served at Inova in 2009-10 as executive vice president, responsible for information technology, biomedical engineering, innovation, international business, compliance, risk, legal, communications, government relations, community affairs and philanthropy.

Prior to returning to Inova, Stottlemyer was CEO of Acentia LCC, a provider of software, information technology and management solutions. In 2013, he was recognized by the Washington Business Journal as one of the Washington, D.C., region's 50 "Most Admired CEOs." In 2014, he was recognized by Virginia Business as one of 31 people "making their mark on the Commonwealth's economy."

Stottlemyer currently serves as rector (chair of the Board of Visitors) of The College of William & Mary, where he received his Bachelor of Arts degree (Phi Beta Kappa). He received a JD (cum laude) from Georgetown University Law Center and is a member of the Virginia State Bar.



Genomics Panel:



Dr. David Delaney
Chief Medical Officer
SAP


David Delaney, MD is chief medical officer and head of the U.S. healthcare team at SAP. He is charged with building and leading SAP's strategic plan for healthcare in the Americas. Delaney is actively engaged in driving co-innovation projects with a particular focus on cutting-edge applications of advanced analytics and in-memory technologies in the provider and payer sectors.

Before joining SAP, he was chief medical officer at MedAptus, a privately-held provider of revenue cycle management solutions. During his tenure, he was responsible for business development and product management, successfully launching two major products.

Prior to MedAptus, Delaney was director of web development and applied informatics at Boston's Beth Israel Deaconess Medical Center, a core Harvard Medical School teaching hospital where he led development of a number of highly visible, award-winning applications.

Delaney is a board certified critical care physician with 14 years of practice as an intensivist at Beth Israel Deaconess Medical Center (BIDMC), where he also held a teaching appointment at Harvard Medical School. At BIDMC he held various leadership positions including director of web development and applied informatics and associate director of medical critical care.

He holds a B.A. from Wheaton College, and received his medical degree from State University of New York, Syracuse. His postgraduate medical education was completed at Harvard Medical School, including residency training in internal medicine at Beth Israel Deaconess Medical Center, the Harvard Combined Fellowship in Pulmonary Disease and Critical Care Medicine, and a Harvard/National Library of Medicine Fellowship in Medical Informatics.



Steve Halliwell
Director, Healthcare and Life Sciences Sector
Amazon Web Services


Steven Halliwell has been implementing technology solutions and building technology teams in transportation, retail, life sciences, distribution and public sector vertical markets for more than 20 years. He currently directs Amazon Web Services' (AWS) Healthcare and Life Sciences team to identify vital strategies, drive customer engagement and evangelize new IT paradigms enabled by an elastic computing model.

His experience spans mainframe, client server and cloud technologies in project management, sales, and marketing and business development capacities.

Halliwell has a bachelor's degree in organizational development, and started his career programming mainframes for human resource workloads. He then moved into n-tier architectures as an IT consultant, and from there into sales and business management for Microsoft, where he managed their state and local government business from Maryland to Florida. In 2009 he moved to Hewlett Packard as a regional director and assumed added responsibility for the education vertical for much of the U.S. In 2011 Halliwell joined Amazon Web Services' Government and Education group in 2011 as employee #1. In that role he worked closely with academic medical centers and research organizations around the world, and assisted in creating AWS' HIPAA Business Associate program. In 2014 Halliwell was chosen to stand up a new vertical focus for Amazon Web Services, chartered with assisting AWS evaluate, migrate and operate within the HCLS vertical market.



Crystal R. Icenhour, Ph.D.
CEO
Aperiomics


Crystal R. Icenhour received her Ph.D. in pathobiology and molecular medicine from the University of Cincinnati Medical School of Graduate Studies in 2002. She conducted postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College of Medicine from 2002-2005 and in the Department of Infectious Diseases at Duke University Medical Center from 2005-2006. Icenhour has been involved in local and national postdoctoral associations including the Mayo Research Fellows Association Executive Committee (president), the Duke University Postdoctoral Association (chair of membership committee), and the National Postdoctoral Association (2008 chair). Icenhour was president and chief science officer for Phthisis Diagnostics, a biotechnology company located in Charlottesville, Virginia from 2007-2013. In 2014 Icenhour was recruited as CEO of Aperiomics in Sterling, Virginia. Aperiomics' focus is to harness the power of next-generation sequencing to improve world health.



Dr. Emanuel F. Petricoin
Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM)
George Mason University


Dr. Emanuel F Petricoin has been the co-director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a university professor. Prior to this position, he served as co-director of the FDA-NCI Clinical Proteomics Program and a senior investigator within the Center for Biologics Evaluation and Research at the FDA from 1993-2005. Petricoin received his Ph.D. in microbiology from the University of Maryland in 1990. The focus of the CAPMM is the invention and use of proteomics technologies for personalized therapy, molecular diagnostics and biomarker discovery.

He also is a co-founder of four life science companies, including two precision medicine companies: Theranostics Health Inc. and Perthera Inc., located in McClean Va., where he is a co-founder and chief science officer. He is a co-inventor on 40 filed and published patents, and has authored more than 360 peer-reviewed publications and invited reviews. In addition, he has authored more 40 book chapters, is on the editorial board of Proteomics, Biomedical Microdevices, Proteomics - Clinical Applications, Proteomics - Protocols, Molecular Carcinogenesis, Journal of Personalized Medicine and is a senior editor for Cancer Epidemiology Biomarkers and Prevention.

Petricoin is a founding member of the Human Proteomic Organization (HUPO) as well as the U.S. HUPO and served as treasurer and a member of the executive committee for HUPO from 2002 to 2004. He has received numerous awards, including the university professorship at George Mason University, the NIH Director's Award, FDA Distinguished Scientist Award, 2015 Innovator of the Year Award, GAP50 Top Virginia Entrepreneurs, Nifty 50 Award, American Society of Cytopathology Basic Research Award, the Roche Diagnostics/CLAS Distinguished Scientist Award and the Harvard University Leading Edge Award and is s Kentucky Colonel. He is the faculty representative to the George Mason University Research Foundation and represents GMU on the Board of Directors for the Virginia Health Research Biosciences Corporation.



Moderator
Aaron Black
Director of Informatics
Inova Translational Medicine Institute


Aaron Black is the director of informatics for the Inova Translational Medicine Institute (ITMI). ITMI was established in 2011 to provide precision medicine as part of the Inova's vision of being a destination health care provider in the greater Virginia and Washington, D.C. area. Black joined ITMI in October 2013 to build a world class informatics team and IT infrastructure to support one of the largest and diverse genomic datasets in the world. Black is currently building a team to design and create a flexible, resilient and scalable IT infrastructure to support the collection, storage, visualization and distribution of genomic, clinical and laboratory data. It is ITMI's vision to quicken the rate of discovery of therapies and interventions that will enhance the services provided by the Inova and its partners. Black and team are creating a hybrid IT architecture of cloud and on premise technologies to support the ever changing data that are being collected as part of numerous ITMI studies. Black has been a featured speaker and panelist at National Conferences and Councils including the Consumer Electronics Show (CES), Precision Medicine World Conference, Amazon Re:Invent, NetApp, Epic, HIMSS and an invited speaker at the National Research Council's Standing Committee on Biological and Physical Sciences in Space (CBPSS).

Black is a member of the Virginia Health Information Technology Standards (HITSAC) Genomics Working Group, which members investigate requirements within the Commonwealth of Virginia for health IT standards to support personalized medicine, clinical genomics, genetic research and related bioinformatics. He is also a member of EPIC's genomics working group that advises the EHR vendor on the design and storage of data within the EHR.

Before coming to ITMI, Black was the manager of informatics for Nationwide Children's Hospital (NCH) in Columbus, Ohio. In the fall of 2008, NCH was awarded to become the second Biospecimen Core Resource (BCR) as the National Cancer Institute's (NCI) Cancer Genome Atlas program (TCGA). TCGA is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing.

Black was the first Informatics hire for the NCH BCR, and was the key architect in implementing informatics and IT applications, processes and infrastructure to support the largest federally funded project in this history of the National Institutes of Health (NIH). In his four years at NCH, Black built a team of architects, developers, engineers and analysts to support the TCGA project as well as NCH becoming the biospecimen and clinical data resource for other NCI sponsored projects that processed and collected data for biological specimens around the world. Black also helped lead the NCH team to become and accredited biospecimen repository by the College of American Pathologists (CAP) and National Institute of Standards and Technology (NIST) accredited. As part of the TCGA network, Black is a co-author on many scientific publications in prestigious journals such as Nature and the New England Journal of Medicine.

Black graduated from Miami University in Ohio with degrees in accounting and management information systems, and spent a summer at Miami's International Business program in Luxembourg studying economics. After college, Black was a consultant for a regional accounting firm in Cincinnati, Ohio, leading implementations of business and accounting software. He also was the lead in opening up a Columbus Office for the firm. Black then moved on to a startup company in Columbus, Ohio, where he managed implementation projects for medical billing systems. He led dozens of successful conversions and software implementations targeting medical institutions who were billing Medicare, Medicaid and private insurance for their patient services.

Black is a certified Project Management Professional (PMP), a Certified Scrum Master (CSM) and has dozens of technical certifications from Microsoft and accounting software vendors.



Digital Health Panel:



Mike Baird
CEO
Avizia


Mike Baird founded Avizia with a mission to improve patient outcomes and expand the reach of healthcare through technology. As a parent of five kids, he has interacted with hospitals, emergency rooms, and physicians on a regular basis and thinks we can do better.

A passionate technologist, Baird is constantly looking for ways to take cutting edge technology and make it affordable, approachable, and easy to use. Prior to Avizia, Baird held senior positions leading strategy, marketing, and product development teams at Tandberg, Cisco, McKinsey & Co, and Dell.

Baird holds an MBA with distinction from the Kellogg School of Management at Northwestern University and was designated in 2005 as a Siebel Scholar.



Paul Clark
Director of Healthcare Research
Digital Reasoning Systems Inc.


Paul Alexander Clark serves as director of healthcare research for Digital Reasoning Systems Inc. A data scientist and healthcare services delivery expert, Clark's research has been published in dozens of peer-reviewed journals and presented at hundreds of conferences. Over his 17 year career in healthcare, Clark led research and technology initiatives across a variety of organizations including startups, nonprofit scientific associations, publicly-traded research firms and private think-tanks. He earned multiple graduate degrees in healthcare, science and technology policy.



John Lettow
CEO Vorbeck Materials


John Lettow is the president and co-founder of Vorbeck Materials Corp. The company develops specialty electronics for wearable and communications devices, as well as batteries and other components based on a fundamental new material technology - graphene. Customers include leading consumer goods and apparel companies, health-care firms, and electronics and aerospace companies. Lettow has experience in technology development, startup companies, and consulting with a focus on materials innovations in the electronics and energy industries. Lettow has received a Ph.D. in chemical engineering from MIT, an M.Phil. in engineering from the University of Cambridge (UK) as a Fulbright Scholar, a BSE in chemical engineering from Princeton University, and an MBA from the Wharton School, University of Pennsylvania. Lettow serves on the Advisory Board for the Department of Chemical and Biological Engineering at Princeton University, and he has served on the Advisory Board for the Maryland Center for Entrepreneurship.



Dr. Randall Moorman
Professor of Medicine, Biomedical Engineering and Molecular Physiology and Biological Physics
University of Virginia


Randall Moorman, MD, is professor of internal medicine, physiology and biomedical engineering. He was educated at the University of Mississippi and its School of Medicine, and trained in internal medicine and cardiology at Duke University. He served as chief resident in Medicine at Duke.

He and his coworkers have worked in the field of predictive monitoring since 2000, and developed heart rate characteristics monitoring for neonatal sepsis, a non-invasive informatics-based technology that reduced the NICU death rate by more than 20 percent in a very large clinical trial. Their work now centers on early detection of subacute potentially catastrophic illness in adult patients.



Jonathon Perrelli
CEO
LifeFuels


Jonathon Perrelli is CEO and co-founder of LifeFuels (lifefuels.co), his seventh startup venture. Lifefuels curates nutrition and hydration through three integrated technology components: a smart nutrition bottle; FuelPods that dispense vitamins, minerals, supplements, flavors, and ultimately medicine; and the LifeFuels app which orchestrates the consumer experience (dispensing, tracking, buying and sharing) and integrates with wearables. Perrelli has exited five of his six companies and his most recent success was the 2014 sale of SecureForce, a cybersecurity firm in Washington, D.C. where he served as CEO and Chairman.

An early-stage technology investor, Perrelli founded Fortify Ventures (Fortify.vc) in 2011 and has invested in more than 40 early stage and emerging technology companies. He co-created the pitch event series 'Distilled Intelligence' (distilledintelligence.com) and co-founded 'The Fort' which was Washington, D.C.'s first tech accelerator. While operating The Fort, Perrelli teamed with film director Justin Gutwein to create Startupland, a documentary and educational series about the five companies in the second class of The Fort. Startupland.tv has premiered in over 75 countries since March 2014 and a 15-week online course for entrepreneurs.

Perrelli currently serves as a Founders Circle and Board member to The Virginia Tech APEX Systems Center of Innovation and Entrepreneurship. He is also an Advisory Board member to The Vinetta Project, and serves on the Board of Directors for IntroHive and Talk Local.

Previously, he served as a delegate to the United Nations Foundation Global Accelerator, he was a founding advisor to 1776 in D.C., and has judged dozens of pitch competitions and startup weekends. He is a frequent speaker on topics related to entrepreneurship, fundraising, accelerators, startup ecosystems, and building emerging technology companies.

A single father to three young children, Perrelli strives to achieve balance between LifeFuels, travel, family activities, and everything in between. Carpe Diem isn't a proverb, it's a way of life. Perrelli is a graduate and active alumni of Virginia Tech where he studied psychology, computer science, and finance.



Moderator
Sunil Budhrani
Chief Medical Officer
Innovation Health


Sunil Budhrani is a board certified emergency medicine physician who graduated from the University of Pennsylvania with a degree in neuroscience and English. He went on to complete his medical degree at the George Washington University, where he then pursued his Master's in public health due to an interest in population gealth dynamics. Subsequently, he completed his residency training in emergency medicine at the Tufts University School of Medicine in Massachusetts, and went on to chair and direct emergency departments and urgent care centers throughout the East Coast.

Budhrani then served as the chief medical officer of the Evergreen Health Cooperative Insurance for the State of Maryland and led the clinical course for medical technology, network development, member engagement and population health for the plan. He co-founded CareClix Telemedicine, a leading pioneer in telemedicine and remote patient monitoring technologies with users throughout the United States and abroad. He also served as chair of the American Telemedicine Association's Guidelines Committee for Practice of Primary Care and Urgent Care Telemedicine, has authored many papers on the subject of telemedicine and is a national speaker on virtual medical care on such topics as reducing hospital readmissions and employing telemedicine in medical practices. He currently serves as the chief medical officer of Innovation Health Insurance, a uniquely successful partnership between Aetna and one of the largest health systems in the Washington, D.C. metropolitan area, Inova Health System. He currently resides in Northern Virginia with his wife and two daughters.